Long-acting beta-agonists and long-acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary disease

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Published:

16 April 2018

Authors:

Sarai M, Sin D, FitzGerald J, Aaron S

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Sarai M, Sin D, FitzGerald J, Aaron S. Long-acting beta-agonists and long-acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2018, Issue 4. Art. No.: CD011282. DOI: 10.1002/14651858.CD011282.pub2